| Title | Geography | Industry | ||||
|---|---|---|---|---|---|---|
| Number of ongoing Clinical Trials (for drugs) involving Acromegaly by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hypothyroidism by Phase | Other Industry Indicators | India | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Goiter by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Unspecified Hormonal Disorders by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Adrenal Gland Disorders by Phase | Other Industry Indicators | Ireland | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Euthyroid Sick Syndrome by Phase | Other Industry Indicators | Taiwan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Primary Hyperaldosteronism by Phase | Other Industry Indicators | Germany | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Idiopathic Short Stature by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hirsutism by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Growth Disorders by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Thyroiditis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hyperthyroidism by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Adrenocortical Hyperfunction by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hyperparathyroidism by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hyperaldosteronism by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Precocious Puberty by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hyperandrogenism by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Thyroid Gland Disorders by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Inappropriate ADH Syndrome (Syndrome Of Inappropriate Antidiuretic Hormone Hypersecretion) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Primary Hyperparathyroidism by Phase | Other Industry Indicators | Russia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hypopituitarism by Phase | Other Industry Indicators | India | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hormone Replacement Therapy (HRT) by Phase | Other Industry Indicators | Brazil | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hypoparathyroidism by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Graves Diseases by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Dwarfism by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Secondary Hyperparathyroidism by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Addison's Disease (Primary or Chronic Adrenal Insufficiency) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Sex Differentiation Disorders by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Shox Deficiency by Phase | Other Industry Indicators | Japan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Endocrine Gland Disorders by Phase | Other Industry Indicators | Mexico | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Pituitary Gland Disorders by Phase | Other Industry Indicators | Japan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hyperprolactinaemia by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Gigantism by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hashimoto Thyroiditis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Gonadal Diseases by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Female Hypogonadism by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hormonal Disorders by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Growth Hormone Deficiency by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Adrenal Insufficiency by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Central Precocious Puberty by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hypoestrogenism by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hormone Deficiency Disorders by Phase | Other Industry Indicators | Turkey | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) by Phase | Other Industry Indicators | Italy | Number of clinical trials for drugs | Healthcare | Oct 2021 |
Still looking?
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Explorer
Access more premium companies when you subscribe to Explorer